First Light Asset Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Xenon Pharmaceuticals
XENE
|
+$36.9M |
| 2 |
Alphatec Holdings
ATEC
|
+$35.2M |
| 3 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
+$22.6M |
| 4 |
NeoGenomics
NEO
|
+$14.7M |
| 5 |
Inspire Medical Systems
INSP
|
+$14.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Orthofix Medical
OFIX
|
+$23.8M |
| 2 |
Tandem Diabetes Care
TNDM
|
+$22.4M |
| 3 |
Structure Therapeutics
GPCR
|
+$18.9M |
| 4 |
Zentalis Pharmaceuticals
ZNTL
|
+$17M |
| 5 |
Health Catalyst
HCAT
|
+$15.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 95.85% |
| 2 | Communication Services | 3.34% |
| 3 | Industrials | 0.69% |
| 4 | Miscellaneous | 0.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Genmab
GMAB
$21.2B
| – | – |
-157,147
| Closed | -$5.54M |
|
|
77
Structure Therapeutics
GPCR
$2.53B
| – | – |
-374,412
| Closed | -$18.9M |
|
78
Keros Therapeutics
KROS
$213M
| – | – |
-421,438
| Closed | -$13.4M |
|
79
MaxCyte
MXCT
$122M
| – | – |
-1,073,110
| Closed | -$3.35M |
|
|
80
Orthofix Medical
OFIX
$363M
| – | – |
-1,852,438
| Closed | -$23.8M |
|
81
Outset Medical
OM
$58.6M
| – | – |
-68,088
| Closed | -$11.1M |
|
82
Omnicell
OMCL
$1.48B
| – | – |
-309,244
| Closed | -$13.9M |
|
|
83
Zentalis Pharmaceuticals
ZNTL
$293M
| – | – |
-848,477
| Closed | -$17M |
|
|
OKUR
84
OnKure Therapeutics
OKUR
$117M
| – | – |
-27,232
| Closed | -$2.07M |
|
|
CUTR
85
DELISTED
Cutera, Inc.
CUTR
| – | – |
-240,078
| Closed | -$1.45M |
|
|
MIRO
86
DELISTED
Miromatrix Medical Inc. Common Stock
MIRO
| – | – |
-2,278,670
| Closed | -$2.99M |
|
Similar funds
First Light Asset Management's Q4 2023 Portfolio in Review
As of Q4 2023, First Light Asset Management held 86 positions worth $1.24B, up 18% from $1.05B the previous quarter. Its ten largest holdings account for 53% of the portfolio.
First Light Asset Management deployed $44.3M of net new capital in Q4 2023, opening 11 new positions and adding to 17 existing holdings. Its largest new stake was Shockwave Medical, Inc. Common Stock: 119,623 shares worth $22.8M.
By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 96% a quarter earlier, followed by Communication Services and Industrials.
On the sell side, the largest reduction was Tandem Diabetes Care, an estimated $22.4M trimmed.
- First Light Asset Management's largest Q4 2023 buy was Shockwave Medical, Inc. Common Stock: 119,623 shares worth $22.8M.
- First Light Asset Management added most to Xenon Pharmaceuticals in Q4 2023, an estimated $36.9M increase.
- First Light Asset Management's biggest Q4 2023 reduction was Tandem Diabetes Care, cutting an estimated $22.4M.
- First Light Asset Management fully exited Orthofix Medical in Q4 2023, selling an estimated $23.8M.
- First Light Asset Management's ten largest holdings make up 53% of its $1.24B portfolio in Q4 2023.
- First Light Asset Management opened 11 new positions and closed 11 in Q4 2023.
- First Light Asset Management's portfolio value rose 18% quarter-over-quarter to $1.24B.
Based on First Light Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.